[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371116-105":59,"doc-detail-371116-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mutant-p53-regulates-pyruvate-dehydrogenase-kinase-1-pdk1-to-promote-proliferation-and-migration-in-breast-cancer","Mutant p53 Regulates Pyruvate Dehydrogenase Kinase 1 (PDK1) to Promote Proliferation and Migration in Breast Cancer","","Tumor suppressor p53 is frequently mutated in cancers, and mutant p53 (mutp53) gains oncogenic functions that support tumor progression. This study identifies a mechanism in TP53-mutant breast cancer in which pyruvate dehydrogenase kinase 1 (PDK1) modulates both wild-type and mutant p53 to enhance proliferation and migration. Wild-type p53 represses PDK1 transcription, while mutp53 activates PDK1 via an EGR1 axis, and PDK1 stabilizes mutp53 by blocking degradation. PDK1 inhibition also strengthens APR-246 antitumor effects in xenograft models, suggesting PDK1 as a therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mutant-p53-regulates-pyruvate-dehydrogenase-kinase-1-pdk1-to-promote-proliferation-and-migration-in-breast-cancer/371116/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mutant-p53-regulates-pyruvate-dehydrogenase-kinase-1-pdk1-to-promote-proliferation-and-migration-in-breast-cancer/371116.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-22","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does wild-type p53 regulate PDK1 in breast cancer cells?","Question",{"text":112,"@type":113},"Wild-type p53 directly represses PDK1 transcription, limiting PDK1 expression. This repression is described as a novel direct regulatory relationship.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What mechanism allows mutp53 to activate PDK1?",{"text":117,"@type":113},"In TP53 mutant cells, PDK1 transcription is initiated through an EGR1 axis driven by mutp53. This activation supports downstream malignant phenotypes.",{"name":119,"@type":110,"acceptedAnswer":120},"How does PDK1 contribute to mutant p53 stability and cancer progression?",{"text":121,"@type":113},"PDK1 binds to mutp53 and inhibits its degradation, promoting mutp53 protein accumulation. Together with PDK1 upregulation, this forms a positive feedback loop enhancing breast cancer malignancy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371116,1790247641,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Cancer Science  \nORIGINAL ARTICLE  OPEN ACCESS   \nMutant p53 Regulates Pyruvate Dehydrogenase  \nKinase 1 (PDK1) to Promote Proliferation and Migration in Breast Cancer  \nYan Ye1 | Zuli Ou1 | Canling Li1 | Qingyu Liao1 | Qian Zeng1 | Xiaoqian Ju1 | Dian Zhang1 | Yu Wei1 | Xiang Zhang2 | Tao Zhang2 | Kejia Wu1   \n1Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing,  \nChina | 2Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China Correspondence: Tao Zhang ([tumorzzt@163.com](tumorzzt@163.com)) | Kejia Wu ([drwukejia@hospital.cqmu.edu.cn](drwukejia@hospital.cqmu.edu.cn))  \nReceived: 21 February 2025 | Revised: 25 October 2025 | Accepted: 3 November 2025  \nFunding: This study was supported by the National Natural Science Foundation of China (Grant 82073255) .  \nKeywords: APR-246 | breast cancer | mutant p53 | pyruvate dehydrogenase kinase 1 | ubiquitination  \nABSTRACT  \nTumor suppressor p53 is the most frequently mutated gene in cancers. Mutations in p53 not only result in the loss of its classical tumor-suppressive functions but also confer new oncogenic properties. The protein stabilization of mutant p53 (mutp53) is a prerequisite for gain-of-function manifestation. Here, we report the novel mechanism that pyruvate dehydrogenase kinase1 (PDK1) modulates both wild-type and mutant p53, and facilitates proliferation and migration ofTP53 mutant breast cancer. On the one hand, we identified PDK1 as a direct transcriptional repression target of wild-type p53, whereas transcriptional activation of PDK1 in mutp53 cells is initiated by the EGR1 axis. On the other hand, PDK1 promoted mutp53 protein accumulation by binding to mutp53 and inhibiting its degradation. Taken together, mutp53 activated a positive feedback loop by upregulating PDK1 to enhance p53 protein stability and promote the malignancy of breast cancer. Moreover, PDK1 inhibition increased the therapeutic effect of APR-246 on TP53 mutant breast cancer in xenograft tumors. Our results suggested that intervention of PDK1 could potentially emerge as a new therapeutic strategy to impede the progression ofTP53 mutant breast cancer.  \n1 | Introduction  \nBreast cancer (BRCA) is the most common malignant cancer among women worldwide, accounting for 32% of all new diagnoses in female cancers [1] . Tumor progression in breast cancer involves a variety of genetic abnormalities, among which TP53, as the most classical tumor suppressor gene, has been detected in about 47% of breast cancers with abnormal mutations [2–4] . Mutant p53 not only loses its tumor-suppressive functions but  \nalso acquires oncogenic properties. Therefore, clarifying the molecular mechanism of mutp53 is of great significance for finding therapeutic targets for BRCA.  \nTP53 is the most frequently mutated gene inhuman cancers [5, 6] . About 70% of TP53 mutations are missense, most of which are concentrated in the region of the central DNA-binding domain (DBD) of p53 [6–9] . Currently, R175H, R248Q and R273H are the most popular p53 mutation sites reported. These mutations  \n\n| Abbreviations: BRCA, breast cancer; BRCA, breast cancer; CHX, cycloheximide; Co-IP, co-immunoprecipitation; GOF, gain-of-function; IF, immunofluorescence; IHC, immunohistochemistry; Mutp53, mutant p53; PDC, pyruvate dehydrogenase complex; PDK1, pyruvate dehydrogenase kinase 1; Wtp53, wild-type p53 . |\n| --- |\n| Yan Ye, Zuli Ou and Canling Li are co-first authors. |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.\u003Cbr>© 2025 The Author(s). Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. |\n\nCancer Science, 2026; 117:335","cbCaiaMlqYrzvlx3","https://ap.wps.com/l/cbCaiaMlqYrzvlx3","pdf",12268991,18,"English","# Introduction\n## Background on TP53 mutations in breast cancer\n## Role of mutp53 in cancer glucose metabolism\n## PDK1 as a regulator of glucose metabolic reprogramming","[{\"question\":\"How does wild-type p53 regulate PDK1 in breast cancer cells?\",\"answer\":\"Wild-type p53 directly represses PDK1 transcription, limiting PDK1 expression. This repression is described as a novel direct regulatory relationship.\"},{\"question\":\"What mechanism allows mutp53 to activate PDK1?\",\"answer\":\"In TP53 mutant cells, PDK1 transcription is initiated through an EGR1 axis driven by mutp53. This activation supports downstream malignant phenotypes.\"},{\"question\":\"How does PDK1 contribute to mutant p53 stability and cancer progression?\",\"answer\":\"PDK1 binds to mutp53 and inhibits its degradation, promoting mutp53 protein accumulation. Together with PDK1 upregulation, this forms a positive feedback loop enhancing breast cancer malignancy.\"}]","Mutant p53 Regulates Pyruvate Dehydrogenase Kinase 1 (PDK1) to Promote Proliferation and Migration in Breast Cancer | PDF",1790191283,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a096eb0263c84263f2db6689bbb9b447.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54bedfd340e7d88d3735ae111971b235.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c9203147339b8f26cf957842dca5da8.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81e9630f9bc244668cfcf32ad209bd21.webp",980,1287]